Filing Flows › Neurocrine Biosciences (NBIX) › Recalls, complaints & regulation
Neurocrine Biosciences (NBIX): clinical trials and Federal Register
Neurocrine Biosciences (NBIX) beyond its filings: 1 Federal Register document in a year; 20 active clinical trials.
Neurocrine Biosciences' latest quarter
Neurocrine Biosciences, Q3 2026: revenue $1.1B (+41% year over year), operating margin 29.5%, net earnings $206M, operating cash flow $395M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Neurocrine Biosciences have?
20 active studies on ClinicalTrials.gov, 12 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.